Login
From:
Rett Syndrome News
(Uncensored)
subscribe
FDA signs off on pivotal trial design for NGN-401 gene therapy
https://rettsyndromenews.com/news/fda-signs-off-pivotal-trial-design-ngn-401-gene-therapy/
links
backlinks
Tagged with:
news
gene therapy
ngn-401
Neurogene received clearance from the FDA for a pivotal trial of NGN-401, which could support an application for the gene therapy's approval.
Roast topics
Find topics
Find it!
